MedTrace Logo

Effects of Rope Skipping in Cardiopulmonary Fitness in Children

NCT07249671 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 178

Last updated 2025-11-25

No results posted yet for this study

Summary

The study will be conducted in a school setting, involving a randomized control trial (RCT) of 178 children aged 6 to 12. The participants will be divided into two groups: a control group engaging in regular physical education (PE) classes and an experimental group practicing rope skipping for 50 minutes, three times a week, over a period of 8 weeks. Cardiopulmonary fitness will be assessed before and after the intervention using the borg rating scale and talk test of perceived exertion.. Data will be analyzed to determine changes in endurance, heart rate recovery, and lung function between the groups. The expected outcome is a significant improvement in cardiopulmonary parameters among the rope-skipping group, highlighting the exercise's effectiveness in promoting heart and lung health in children.

Conditions

  • Cardiopulmonary

Interventions

OTHER

Rope skipping

Rope skipping exercise performed 50 minutes/ times ( including warm up and cool down session) 3 times / week for 8 weeks

OTHER

unsupervised free play

The control group was engaged in self directed unsupervised free play.

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Moiza Khan, MS-PT · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-10-31
Primary Completion
2026-01-10
Completion
2026-01-16

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07249671 on ClinicalTrials.gov